Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.Business Profile Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of...
Chandan Healthcare has divested its 53.56% stake in Chandan Pharmacy to a group company for Rs 16.77 Cr. This strategic move focuses on higher-margin diagnostics, utilizing proceeds to expand new centers for enhanced profitability and a clearer investor profile.
Chandan Healthcare divests its pharmacy subsidiary for Rs 31.31 Cr to focus on its higher-margin diagnostics business. Proceeds will fund new diagnostic centres, aiming for improved consolidated profitability and a clearer investor profile.
Chandan Healthcare divested its 53.56% stake in Chandan Pharmacy to a group company for ₹16.77 Cr. This strategic move sharpens focus on higher-margin diagnostics. Proceeds will fund new diagnostic centres, aiming to boost consolidated profitability and transparency for investors.
Chandan Healthcare proposes to sell its entire 53.56% stake in Chandan Pharmacy to group firm Chandan Hospital for 16.77 Cr, plus 10% interest on deferred payments. Pharmacy, which will cease to be a subsidiary, contributed 42.94% of consolidated turnover and 6.63% of net worth. Shareholder approval is required.
Chandan Healthcare: Dayal Institute of Medical Sciences withdrew its complaint alleging financial irregularities after an amicable settlement. This development removes previous uncertainty, with the company expecting no adverse impact on its operations or financial position.
